Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Not only balloons: Use-cases and key players in global helium market

Whether you’re seeking exposure to exploration upside or established profitability, the helium market offers compelling candidates for the commodity sleeve of your portfolio. Helium is an essential resource notable for its widespread use-cases and p...
Trevor Abes | September 5, 2024 |

Buzz on the Bullboards: TSX recovering as key stocks eye a comeback

The TSX has been on a rebound, clawing back to levels seen before the great global selloff that marked the beginning of the month. As the market stabilizes, investors are keenly watching certain TSX-listed stocks that have recently faced setbacks but are striving to reg...
Jonathon Brown | August 15, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Hydrogen stocks with top news; Plug, Nucera and DynaCERT in focus

Despite negative quarterly figures, the Plug Power stock has developed positively in recent days. Is this the turnaround for the hydrogen pure play? The Americans recently reported progress on a mega-project. DynaCERT is strengthening its position with an industry ex...
Fabian Lorenz | May 22, 2024 |

Is China getting serious? Rheinmetall and Almonty Industries profit

Is China really preparing for an attack on Taiwan? It is well known that China is massively increasing its gold reserves. But why tungsten, too? After all, China itself is the largest producer of this raw material, which is not only in demand in the arms industry. ...
Fabian Lorenz | April 24, 2024 |

A golden exploration opportunity in Northern Ontario

The following is a transcription of the above video, and The Market Online has edited it for clarity . Centurion Minerals Ltd. (TSXV:CTN) is a Vancouver-based mineral exploration and development company focused on projects located in the Americas. We spoke wit...
Ryan Dhillon | April 15, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Buzz on the Bullboards: The cannabis, tech and oil newsmakers

“The obstacle in the path becomes the path. Never forget, within every obstacle is an opportunity to improve our condition.” That text comes from the 2014 book by businessman Ryan Holiday, “The Obstacle Is the Way: The Timeless Art of Turning T...
Jonathon Brown | March 14, 2024 |

Strategic growth, EBITDA success and new leadership: Ciscom's Q3 2023 update

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Today we are talking with Ciscom Corp. (CSE:CISC) , which is focused on technology-driven marketing and advertising and content management organizations. ...
Brieanna McCutcheon | January 29, 2024 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |
1 2 3 4 5 6 7 8 9 10 ...
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested